Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06074822

Research Biobank From Neuromuscular Biopsy Residues (in the Context of Care)

Constitution of a Collection of Residues of Neuromuscular Biopsies From Patients Taken as Part of Their Health Care at the Bordeaux University Hospital for Neuromuscular Disease and Use for Research Projects

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Neuromuscular diseases are rare diseases for which significant progress has been made in the context of diagnosis thanks to advances in molecular techniques, but the intimate mechanisms of lesion formation remain poorly understood. Advances in cellular and molecular biology, the development of a few animal models, such as transgenic mice, which make it possible to mimic human pathology have made it possible to better understand the physiopathology of these diseases. However, they still do so very imperfectly and incompletely, making it even more necessary than ever to study diseased human muscle tissue to find new avenues of research or to confirm results obtained by experimentation. The purpose of this collection of tissue samples for neuro-muscular purposes is to collect such samples under the best conditions in order to promote basic and translational research on muscle diseases. This is why the CHU de Bordeaux wishes to keep the remainders of samples taken as part of the treatment to constitute a collection of biological samples and associated data kept according to quality standards and in compliance with the regulations in force.

Detailed description

The "COLMYONEU" project is a project to collect leftover frozen neuromuscular biopsy samples from patients taken as part of their health care at the Bordeaux University Hospital for neuromuscular disease. Its main objective is to store, under the conditions of the CRB standard, residual biological samples from patients with neuromuscular symptoms.

Conditions

Interventions

TypeNameDescription
OTHERResidual neuromuscular biopsyrecovery of residual neuromuscular biopsy (nerve ans muscle)

Timeline

Start date
2023-06-26
Primary completion
2053-06-25
Completion
2053-06-25
First posted
2023-10-10
Last updated
2023-10-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06074822. Inclusion in this directory is not an endorsement.